Long-term outcomes when PRP is used ongoing

What does the research actually say about PRP and hair transplants?

PRP has a substantial evidence base in androgenetic alopecia generally — a 2024 meta-analysis examined density gains, and another pooling six studies and 343 participants found PRP plus Minoxidil outperformed either alone. The transplant-specific question differs: a 2025 systematic review on PRP as a transplant adjunct notes the need for long-term follow-up with standardised protocols.

Platelet-rich plasma has a substantial literature in androgenetic alopecia. Kieling and colleagues published a systematic review and meta-analysis in 2024 on whether autologous PRP increases hair density in androgenetic alopecia. Xiao and colleagues published a meta-analysis of PRP combined with Minoxidil, pooling six studies and 343 participants and reporting greater increases in hair density and diameter with combination therapy than with either alone.

For the transplant-specific question, Sindhusen and colleagues published a systematic review in Cureus in 2025 on the efficacy of PRP as an adjunct to hair transplantation — which notes the need for long-term follow-up studies with standardised protocols.

That last point is the crux. The review of the adjunct question concludes by identifying the absence this article is about.

What are the three different PRP claims clinics make, and which has evidence?

Clinics conflate three claims: PRP given at surgery to improve graft outcomes, with a review calling for better data; ongoing PRP courses sold as maintenance, with no long-term outcome data in transplant patients; and PRP as a standalone alopecia treatment, where the meta-analyses sit. Citing AGA evidence for maintenance answers a different question.

It matters which claim is being made, because they have different evidence behind them.

• PRP at the time of surgery, to improve graft outcomes. This is the adjunct question, and it is the one with a systematic review that calls for better long-term data.
• Ongoing PRP courses over years, to maintain density. This is what clinics usually sell as a subscription, and it has no long-term outcome data at all in transplant patients.
• PRP as a treatment for androgenetic alopecia in its own right. This is where the meta-analyses sit, and it is a different intervention from either of the above.

A clinic quoting the AGA meta-analyses in support of an ongoing post-transplant maintenance programme is citing evidence for a different question.

What methodological weaknesses affect the PRP evidence base?

PRP preparation protocols vary enormously between clinics — centrifugation, platelet concentration, activation and injection technique all differ, so 'PRP' is not one product. Studies are also small with inconsistent measures and short follow-up. This does not mean PRP does nothing, but the size and durability of any effect remain unestablished and protocol-specific.

The PRP literature has well-documented weaknesses that are worth knowing before committing to years of sessions.

• Preparation protocols vary enormously between clinics — centrifugation, platelet concentration, activation, injection technique. 'PRP' is not one product.
• Studies are small and outcome measures inconsistent.
• Follow-up is short, typically months.
• Blinding is difficult, and the treatment involves repeated attention that is itself hard to separate from effect.

None of this means PRP does nothing. It means the size of any effect, and its durability, are not established — and that a result from one clinic's protocol does not transfer to another's.

How much does ongoing PRP maintenance cost over ten years compared with medical therapy?

Ongoing PRP repeated two to four times a year for ten years is a substantial cumulative cost paid against an effect size never established over that timeframe. The relevant comparison is Finasteride, which has genuine five-year follow-up data and is far cheaper — a decision for a doctor, not a clinic selling a package.

What questions should you ask before committing to an ongoing PRP programme?

Ask what specific outcome is claimed and from which study, whether that study was in transplant patients or androgenetic alopecia generally, what preparation protocol is used, how success will be measured, and the total cost over five years. A clinic that answers the transplant-versus-AGA distinction accurately is describing the evidence honestly.

• What specific outcome are you claiming, and from which study?
• Is that study in transplant patients or in androgenetic alopecia generally?
• What preparation protocol do you use, and what platelet concentration?
• How will we measure whether it is working — hair counts in a defined zone, or impression?
• What is the total cost over five years, and can I stop?
• Is medical therapy in place, and how does this compare?

A clinic that answers the first two accurately is describing the evidence honestly. The distinction between 'studied in transplant patients' and 'studied in hair loss' is where most of the overreach in this area lives.

Sources

1. Sindhusen S, Tawanwongsri W, Eden C. Efficacy of Platelet-Rich Plasma as an Adjunct to Hair Transplantation: A Systematic Review. Cureus, 2025;17(10):e94116. pubmed.ncbi.nlm.nih.gov/41069573
2. Kieling L, et al. Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis. Anais Brasileiros de Dermatologia, 2024;99(6):847-862. pubmed.ncbi.nlm.nih.gov/39013743
3. Xiao C, et al. Meta-Analysis of Efficacy of Platelet-Rich Plasma Combined with Minoxidil for Androgenetic Alopecia. Aesthetic Plastic Surgery, 2024;48(21):4554-4566. pubmed.ncbi.nlm.nih.gov/38789807
4. Long-term (5-year) multinational experience with Finasteride 1 mg in the treatment of men with androgenetic alopecia. European Journal of Dermatology, 2002. pubmed.ncbi.nlm.nih.gov/11809594
5. Romera de Blas C, Vega Díez D, Ricart Vayá JM, Gómez Zubiaur A. Complications in follicular unit excision hair transplantation: current evidence and practical approaches. Frontiers in Medicine, 2026;13:1750989. pubmed.ncbi.nlm.nih.gov/41709896

This article summarises published research and standard clinical practice. It is general educational information, not medical advice, and it does not replace the instructions your own surgical team gives you. Where their guidance differs from anything here, follow theirs.